Largest pharmaceutical companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Johnson & Johnson leads the 52 pharmaceutical companies ranked by revenue, at DKK 641.7B, ahead of Eli Lilly (DKK 444B) and Merck & Co (DKK 442.9B). Figures as of 19 Nov 2026, 00:16 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 52
- First
- Johnson & JohnsonDKK 641.7B
- Median
- DKK 21.8B
- Combined market value
- DKK 34.46T
- Countries
- 10
- Not ranked
- 9no revenue on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | DKK 641.7B | DKK 4.47T | DKK 1,857.77 | 2.15% down | 38% up | ||
| 2 | Eli LillyLLY · Health Care | DKK 444B | DKK 8.39T | DKK 9,420.01 | 2.32% down | 35% up | ||
| 3 | Merck & CoMRK · Health Care | DKK 442.9B | DKK 2.31T | DKK 938.63 | 3.90% down | 51% up | ||
| 4 | PfizerPFE · Health Care | DKK 426.3B | DKK 1.09T | DKK 191.16 | 1.44% down | 14% up | ||
| 5 | AbbVieABBV · Health Care | DKK 416.7B | DKK 3.44T | DKK 1,948.45 | 2.33% down | 26% up | ||
| 6 | AstraZenecaAZN · Health Care | DKK 400.2B | DKK 1.89T | DKK 1,217.81 | 1.93% down | 2% up | ||
| 7 | NovartisNVS · Health Care | DKK 371.5B | DKK 2T | DKK 1,057.37 | 2.46% down | 25% up | ||
| 8 | SanofiSNY · Health Care | DKK 329.7B | DKK 770.8B | DKK 321.01 | 0.86% down | 4% down | ||
| 9 | Bristol-Myers SquibbBMY · Health Care | DKK 328.3B | DKK 829.4B | DKK 405.75 | 2.92% down | 34% up | ||
| 10 | Novo NordiskNVO · Health Care | DKK 312.5B | DKK 1.18T | DKK 268.62 | 3.12% down | 17% down | ||
| 11 | Abbott LaboratoriesABT · Health Care | DKK 302B | DKK 1.23T | DKK 711.77 | 0.22% down | 17% down | ||
| 12 | GSKGSK · Health Care | DKK 295.4B | DKK 663.4B | DKK 330.95 | 1.34% down | 6% up | ||
| 13 | Takeda PharmaceuticalTAK · Health Care | DKK 192.2B | DKK 462.9B | DKK 144.90 | 1.71% down | 54% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | DKK 117.6B | DKK 335.7B | DKK 287.69 | 0.92% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | DKK 97.7B | DKK 666.4B | DKK 6,441.44 | 1.28% down | 36% up | ||
| 16 | ViatrisVTRS · Health Care | DKK 97.4B | DKK 158.4B | DKK 138.16 | 0.83% down | 96% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | DKK 81.8B | DKK 926.6B | DKK 3,654.58 | 0.42% up | 27% up | ||
| 18 | ZoetisZTS · Health Care | DKK 64.5B | DKK 236.9B | DKK 582.95 | 2.50% up | 29% down | ||
| 19 | GrifolsGRFS · Health Care | DKK 56.9B | DKK 39.3B | DKK 57.70 | 1.85% down | 1% up | ||
| 20 | BeOne MedicinesONC · Health Care | DKK 36.4B | DKK 314.1B | DKK 2,749.53 | 2.34% down | 17% up | ||
| 21 | Elanco Animal HealthELAN · Health Care | DKK 32.1B | DKK 90.9B | DKK 181.89 | 3.29% up | 20% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | DKK 29.1B | DKK 108.3B | DKK 1,687.94 | 2.93% up | 37% up | ||
| 23 | GenmabGMAB · Health Care | DKK 25.3B | DKK 214.1B | DKK 347.23 | 1.91% down | 70% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | DKK 25.3B | DKK 136.3B | DKK 1,017.79 | 4.54% down | 66% down | ||
| 25 | Dr. Reddy's LaboratoriesRDY · Health Care | DKK 24.4B | DKK 85.1B | DKK 102.05 | 1.28% up | 5% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | DKK 21.9B | DKK 81.1B | DKK 418.49 | 4.99% up | 11% up | ||
| 27 | United TherapeuticsUTHR · Health Care | DKK 21.7B | DKK 167.5B | DKK 3,933.14 | 1.16% down | 23% up | ||
| 28 | Amneal PharmaceuticalsAMRX · Health Care | DKK 20.6B | DKK 51.9B | DKK 149.06 | 3.60% up | 83% up | ||
| 29 | Royalty PharmaRPRX · Health Care | DKK 16.2B | DKK 269B | DKK 467.82 | 0.01% down | 78% up | ||
| 30 | PTC TherapeuticsPTCT · Health Care | DKK 11.8B | DKK 34.3B | DKK 410.32 | 0.22% down | 20% down | ||
| 31 | AlkermesALKS · Health Care | DKK 10.1B | DKK 53.6B | DKK 319.17 | 3.08% up | 58% up | ||
| 32 | Legend BiotechLEGN · Health Care | DKK 7B | DKK 21.5B | DKK 110.70 | 0.87% up | 42% down | ||
| 33 | Madrigal PharmaceuticalsMDGL · Health Care | DKK 6.5B | DKK 63B | DKK 2,711.93 | 5.67% down | 24% down | ||
| 34 | Ionis PharmaceuticalsIONS · Health Care | DKK 6.4B | DKK 31.1B | DKK 186.59 | 1.59% up | 64% down | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | DKK 5.7B | DKK 41.5B | DKK 293.69 | 0.28% up | 10% up | ||
| 36 | Ascendis PharmaASND · Health Care | DKK 5.4B | DKK 120.8B | DKK 1,841.63 | 0.32% down | 28% up | ||
| 37 | Corcept TherapeuticsCORT · Health Care | DKK 5.2B | DKK 50.5B | DKK 461.82 | 3.25% down | 8% down | ||
| 38 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | DKK 4.6B | DKK 50.9B | DKK 647.53 | 0.06% down | 126% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | DKK 4.3B | DKK 48B | DKK 912.88 | 1.43% down | 7% down | ||
| 40 | TG TherapeuticsTGTX · Health Care | DKK 4.2B | DKK 68.1B | DKK 450.44 | 5.44% up | 107% up | ||
| 41 | InsmedINSM · Health Care | DKK 4.1B | DKK 179B | DKK 816.14 | 1.69% down | 40% down | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | DKK 3.6B | DKK 41.1B | DKK 630.09 | 0.59% up | 31% up | ||
| 43 | BridgeBio PharmaBBIO · Health Care | DKK 3.4B | DKK 103.5B | DKK 531.44 | 1.58% up | 17% up | ||
| 44 | Travere TherapeuticsTVTX · Health Care | DKK 3.3B | DKK 32.9B | DKK 342.26 | 1.68% down | 44% up | ||
| 45 | Ligand PharmaceuticalsLGND · Health Care | DKK 1.8B | DKK 40.7B | DKK 2,034.97 | 1.67% up | 43% up | ||
| 46 | Rhythm PharmaceuticalsRYTM · Health Care | DKK 1.3B | DKK 56.2B | DKK 810.96 | 2.08% up | 13% up | ||
| 47 | CytokineticsCYTK · Health Care | DKK 599.8M | DKK 48.7B | DKK 349.62 | 0.64% down | 20% down | ||
| 48 | Protagonist TherapeuticsPTGX · Health Care | DKK 313.5M | DKK 56.5B | DKK 866.28 | 2.00% up | 46% up | ||
| 49 | Roivant SciencesROIV · Health Care | DKK 56.3M | DKK 191.2B | DKK 263.85 | 0.05% up | 90% up | ||
| 50 | Dianthus TherapeuticsDNTH · Health Care | DKK 13.9M | DKK 32.2B | DKK 572.12 | 3.45% down | 113% up | ||
| 51 | Spyre TherapeuticsSYRE · Health Care | DKK 0 | DKK 65.6B | DKK 691.20 | 8.15% up | 286% up | ||
| 52 | Praxis Precision MedicinesPRAX · Health Care | DKK 0 | DKK 58.1B | DKK 2,079.11 | 0.04% up | 61% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8125 DKK). 9 companies have no revenue on file and are not ranked here.
Questions and answers
Which pharmaceutical companies rank first by revenue?
Johnson & Johnson (DKK 641.7B), Eli Lilly (DKK 444B) and Merck & Co (DKK 442.9B) are the top three of the 52 pharmaceutical companies ranked by revenue as of 19 Nov 2026, 00:16 UTC.
How many pharmaceutical companies are in this ranking?
52 are ranked by revenue. 9 more have no revenue on file and are left out rather than ranked at zero.
What are these pharmaceutical companies worth together?
The 52 pharmaceutical companies ranked by revenue have a combined market value of DKK 34.46T as of 19 Nov 2026, 00:16 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies by revenue”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.